All results
514 results
-
A Study to Evaluate the PK, Safety, Efficacy, and PD With ATB200/AT2221 in LOPD Subjects
This is a Phase 3, open-label, multicenter study to evaluate the safety, PK, efficacy, PD, and immunogenicity of Cipaglucosidase Alfa/Miglustat treatment in…
- Ages
- 0 Years - 17 Years
- Sexes
- All
-
A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment o
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia…
- Ages
- N/A - 22 Years
- Sexes
- All
-
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Ap
Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or…
- Ages
- 0 Years - 25 Years
- Sexes
- All
-
A multicenter, open-label extension study to assess the long-term safety and tolerability of dapirol
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment. ### Inclusion Criteria: * The participant could,…
- Ages
- 16 Years - N/A
- Sexes
- All
-
A2AR and breathing in ALS
The purpose of this research study is to determine the effects of a medication, istradefylline, in conjunction with breathing air with reduced oxygen for short…
- Ages
- 21 Years - 80 Years
- Sexes
- All
-
AAOS Registry
-
ABRuPT2
This is a prospective randomized multi-center study which will compare acute fluid resuscitation using a colloid strategy (LR + 5% Albumin) to a crystalloid…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ABX Nail Study
This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ACCQUIREnet
-
ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)
The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…
- Ages
- 18 Years - N/A
- Sexes
- All